<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND:   <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is one of the most rapidly increasing <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in the world, and accumulation of alterations in oncogenes, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor genes and mismatch repair (MMR) genes contributes to colorectal <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Thus, we investigated the alterations of 14 microsatellite loci adjacent to MMR genes, p53, <z:mpath ids='MPATH_271'>adenomatous polyposis coli</z:mpath> (APC) and K-ras in 52 Chinese patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIALS AND METHODS:   We performed fluorescent polymerase chain reaction and capillary electrophoresis to analyse microsatellite instability (MSI) and loss of heterozygosity (LOH) in microsatellite loci, which included a panel of nine <z:chebi fb="0" ids="47885">dinucleotide</z:chebi> repeats and the Bethesda consensus panel </plain></SENT>
<SENT sid="3" pm="."><plain>Additionally, we screened for mutations in exons 4-9 of p53 and the mutation cluster region (MCR) in APC by DHPLC </plain></SENT>
<SENT sid="4" pm="."><plain>Codons 12, 13 and 61 in K-ras were analysed using direct sequencing </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> variations were confirmed using clone sequencing </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS:   The alteration frequency of microsatellite DNA was 55·8% (29/52) </plain></SENT>
<SENT sid="7" pm="."><plain>Among the microsatellites, five loci exhibited MSI and another nine loci exhibited LOH </plain></SENT>
<SENT sid="8" pm="."><plain>The mutation rates of p53, APC and K-ras were 42·3%, 38·5% and 36·5%, respectively </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients (n = 7) with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> had a mutation in p53, APC or K-ras </plain></SENT>
<SENT sid="10" pm="."><plain>APC mutation was correlated with clinical stage and the presence of lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (P = 0·001 and P = 0·006, respectively) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS&gt;   A total of 80·8% of Chinese patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> show variations in microsatellite DNA, p53, APC or K-ras </plain></SENT>
<SENT sid="12" pm="."><plain>It appears that these microsatellite DNA alterations could be a new biomarker for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>